Drugs and Therapeutics Committee
|Drugs and Therapeutics (D & T) Committee |
|Drugs Under Review for: |
|December 16, 2015 |
|Drug Name |Review Type |Class |Manufacturer |
|Kitabis |New Drug Initial Review |Cystic Fibrosis |PARI Respiratory Equipment, Inc. |
|Aristada |New Drug Initial Review |Schizophrenia |Alkermes |
|Jadenu |New Drug Initial Review |Iron Chelator |Novartis |
|Copaxone 40mg SQ |New Drug Initial review |Multiple Sclerosis |Teva |
|Repatha |New Drug Initial Review |High Cholesterol |Amgen |
|Genvoya |New Drug initial Review |HIV |Gilead |
|Feraheme |New Drug Appeal |Intravenous Iron |Amag |
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- supreme committee for delivery and legacy
- drugs and their metabolites list
- common cardiac drugs and generics
- webmd drugs and medication
- webmd drugs and medication search
- committee member roles and responsibilities
- top 200 drugs and classifications
- vasoactive drugs and receptors
- articles about drugs and alcohol
- ototoxic drugs and tinnitus
- drugs and what they treat
- treasurer and committee roles and responsibilities